Literature DB >> 18291097

Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage.

Wang-Ju Hsieh1, Shu-Chen Hsieh, Chia-Chen Chen, Fung-Fang Wang.   

Abstract

Mouse DDA3 (mDDA3) is a microtubule-associated protein that promotes cell growth. mDDA3 contains an intronic p53 binding motif that is absent in human DDA3 (hDDA3), and is transcriptionally activated during DNA damage in a p53-dependent way. We now report that hDDA3 mRNA and protein levels were suppressed by p53, as well as in DNA damaged cells harboring wild type, but not mutant-p53 expression. We have located three consensus El-Deiry decamers at -1478/-1403 of the hDDA3 gene, and shown by chromatin immunoprecipitation that p53 bound to the region. Luciferase analysis showed that the hDDA3 promoter containing the putative p53 binding motif was responsible for p53-mediated repression. Expression of hDDA3 decreased the cell's requirement for serum, furthermore, overexpression of hDDA3 mRNA was detected in hepatoma tissues. Together our results show that hDDA3 is a p53- and DNA-damage down-regulated target that exhibits oncogenic characteristics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18291097     DOI: 10.1016/j.bbrc.2008.02.047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Phospho-regulation of DDA3 function in mitosis.

Authors:  Chang-Young Jang; Judith A Coppinger; John R Yates; Guowei Fang
Journal:  Biochem Biophys Res Commun       Date:  2010-02-01       Impact factor: 3.575

2.  Identification of radiation-induced expression changes in nonimmortalized human T cells.

Authors:  Era L Pogosova-Agadjanyan; Wenhong Fan; George E Georges; Jeffrey L Schwartz; Crystal M Kepler; Hana Lee; Amanda L Suchanek; Michelle R Cronk; Ariel Brumbaugh; Julia H Engel; Michi Yukawa; Lue P Zhao; Shelly Heimfeld; Derek L Stirewalt
Journal:  Radiat Res       Date:  2010-11-17       Impact factor: 2.841

3.  Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study.

Authors:  Jan Bressler; Aaron R Folsom; David J Couper; Kelly A Volcik; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2009-12-02       Impact factor: 4.897

Review 4.  One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor.

Authors:  Levin Böhlig; Karen Rother
Journal:  J Biomed Biotechnol       Date:  2011-03-08

5.  Genes associated with recurrence of hepatocellular carcinoma: integrated analysis by gene expression and methylation profiling.

Authors:  Ju Dong Yang; So-Young Seol; Sun-Hee Leem; Yong Hoon Kim; Zhifu Sun; Ju-Seog Lee; Snorri S Thorgeirsson; In-Sun Chu; Lewis R Roberts; Koo Jeong Kang
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

6.  The transcription factor p53: not a repressor, solely an activator.

Authors:  Martin Fischer; Lydia Steiner; Kurt Engeland
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  TIA1 is a gender-specific disease modifier of a mild mouse model of spinal muscular atrophy.

Authors:  Matthew D Howell; Eric W Ottesen; Natalia N Singh; Rachel L Anderson; Joonbae Seo; Senthilkumar Sivanesan; Elizabeth M Whitley; Ravindra N Singh
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

8.  Dissecting the Mechanism of Action of Spiperone-A Candidate for Drug Repurposing for Colorectal Cancer.

Authors:  Annamaria Antona; Marco Varalda; Konkonika Roy; Francesco Favero; Eleonora Mazzucco; Miriam Zuccalà; Giovanni Leo; Giulia Soggia; Valentina Bettio; Martina Tosi; Miriam Gaggianesi; Beatrice Riva; Simone Reano; Armando Genazzani; Marcello Manfredi; Giorgio Stassi; Davide Corà; Sandra D'Alfonso; Daniela Capello
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

9.  Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.

Authors:  Marion M Malenge; Astri Fjelde Maaland; Ada Repetto-Llamazares; Brian Middleton; Marcel Nijland; Lydia Visser; Sebastian Patzke; Helen Heyerdahl; Arne Kolstad; Trond Stokke; Anne Hansen Ree; Jostein Dahle
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.752

10.  Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.

Authors:  Serhiy Havrylov; Yuriy Rzhepetskyy; Agata Malinowska; Lyudmyla Drobot; Maria Jolanta Redowicz
Journal:  Proteome Sci       Date:  2009-06-16       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.